Oncology (all articles)
Research – The Value of Community Oncology: Site of Care Cost Analysis
17 Oct, 2017 | 18:05h | UTCThe Value of Community Oncology: Site of Care Cost Analysis – Community Oncology Alliance (free PDF)
News release: New Study Determines Cancer Care Delivered In Hospital Outpatient Setting Much More Expensive Than In Independent, Community Oncology Practices (free)
Commentary: Community Cancer Care ‘Much Cheaper’ Than Hospital – Medscape (free registration required)
Review: Obesity and adverse breast cancer risk and outcome
17 Oct, 2017 | 18:04h | UTC
Review – The oncologic burden of hepatitis C virus infection: A clinical perspective
17 Oct, 2017 | 18:01h | UTC
Bladder Cancer – NCCN Clinical Practice Guidelines
17 Oct, 2017 | 17:49h | UTCBladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology (free)
Review: Angiogenesis Inhibitors in NSCLC
17 Oct, 2017 | 17:42h | UTCAngiogenesis Inhibitors in NSCLC – International Journal of Molecular Sciences (free)
Meta-analysis: Adherence to Mediterranean Diet and Risk of Cancer
17 Oct, 2017 | 17:41h | UTC
Review: Chemotherapy for Hepatocellular Carcinoma
17 Oct, 2017 | 17:36h | UTC
Research: Treatment decisions and employment of breast cancer patients
12 Oct, 2017 | 18:18h | UTCTreatment decisions and employment of breast cancer patients: Results of a population-based survey – Cancer (link to abstract – $ for full-text)
Commentaries: Study finds double mastectomy tied to more work absences – eCancer News (free) Aggressive breast cancer treatment tied to more missed work – Reuters (free)
Review – Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment
12 Oct, 2017 | 18:01h | UTCRelated Guidelines and Reviews: Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline (free) AND 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (free) AND Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy (free) AND Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management – CA: A Cancer Journal for Clinicians (free) AND Radiation Associated Cardiac Disease – American College of Cardiology, Latest in Cardiology (free) AND Cardiac Toxicity Of Cancer Chemotherapy – US Cardiology Review (free)
Review: The importance of immunization in cancer prevention, treatment, and survivorship
12 Oct, 2017 | 18:02h | UTC
Review: Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy
12 Oct, 2017 | 17:56h | UTC
Review: managing gastrointestinal stromal tumor
12 Oct, 2017 | 17:51h | UTCRecent advances in managing gastrointestinal stromal tumor – F1000 Research (free)
Review: Uterine sarcoma
12 Oct, 2017 | 17:46h | UTCUterine sarcoma – current perspectives – International Journal of Women’s Health (free)
Meta-analysis: Enhanced recovery program versus traditional care after hepatectomy
12 Oct, 2017 | 17:47h | UTCEnhanced recovery program versus traditional care after hepatectomy: A meta-analysis – Medicine (free)
The Painful Side Of Positive Health Care Marketing
11 Oct, 2017 | 01:37h | UTCThe Painful Side Of Positive Health Care Marketing – NPR (free)
Related: I have cancer. This comic shows how much pressure I feel to be a hero – VOX (free) AND Why cancer is not a war, fight, or battle – CNN (free) AND He’s a Fighter – The Atlantic (free)
Review: Reducing rectal injury in men receiving prostate cancer radiation therapy
9 Oct, 2017 | 20:52h | UTC
Guideline: advanced prostate cancer
9 Oct, 2017 | 20:53h | UTC
Review: Chemotherapy for hepatocellular carcinoma
9 Oct, 2017 | 20:48h | UTCChemotherapy for hepatocellular carcinoma: The present and the future – World Journal of Hepatology (free)
Research: Availability of evidence of benefits on overall survival and quality of life of cancer drugs
7 Oct, 2017 | 22:44h | UTCEditorials: Do cancer drugs improve survival or quality of life? (free) AND Cancer drugs: high price, uncertain value (free)
Commentaries: Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing – The Guardian (free) AND Only half of new cancer drugs extend or improve life – OnMedica (free) AND Some cancer drugs approved in Europe might not have sufficient evidence of survival benefits, says study – Cancer Research UK (free)
Report: Trends in Incidence of Cancers Associated with Overweight and Obesity
7 Oct, 2017 | 22:40h | UTCNews Release: Cancers Associated with Overweight and Obesity Make up 40 percent of Cancers Diagnosed in the United States (free)
Commentaries: Excessive Weight Gain, Obesity, and Cancer Opportunities for Clinical Intervention – JAMA Viewpoint (free) AND Cancer: 40 percent of all cases related to obesity, overweight – Medical News Today (free)
Report: The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
7 Oct, 2017 | 22:38h | UTCCommentary: Global burden of disease study focuses on liver cancer – eCancer News (free)
Opinion – The high price of anticancer drugs: origins, implications, barriers, solutions
7 Oct, 2017 | 22:30h | UTCOpinion: The high price of anticancer drugs: origins, implications, barriers, solutions – Nature Reviews: Clinical Oncology (free PDF)
Related: Cancer drugs are getting better and dearer – The Economist (a few articles per month are free) Financial toxicity: 1 in 3 cancer patients have to turn to friends or family to pay for care – STAT News (free) AND Not Just Nausea And Vomiting: Cancer Docs Now Worry About ‘Financial Toxicity’ – WBUR AND Financial Toxicity and Cancer Treatment (PDQ®) – National Institute of Cancer (free) AND Financial Toxicity: Cancer Supportive Care Professionals Consider the Side Effects of Soaring Costs – ASCO Post (free)
Review: Treatment of advanced, metastatic soft tissue sarcoma
7 Oct, 2017 | 22:03h | UTC
Review – BRCA mutation in ovarian cancer: testing, implications and treatment considerations
7 Oct, 2017 | 22:03h | UTC
Review – Recent developments in the treatment of metastatic colorectal cancer
7 Oct, 2017 | 22:02h | UTC